The CathWorks ffrangio™ system
Quantify. Decide. Confirm*.
Wire-free and drug free 3D FFR guidance, practical
for every case.
Powerful Technology. Impactful Information.
The CathWorks FFRangio™ System combines routine angiograms and advanced
computational science to give you a powerful
and practical CAD decision tool.
See the power of the CathWorks FFRangio™
System for yourself
Request More Info 
Advanced Clinical Decision Tools
Comprehensive physiologic and anatomic insights guide a personalized treatment plan for every patient.
- FFRangio | IMPACT adds important context around the burden of CAD across the full tree.
- FFRangio | PULLBACK shows where FFR drops occur, helping you differentiate diffuse from focal disease and target the most important areas.
- 3D QCA provides estimates of lesion and vessel sizes to aid in procedural planning.
Treat Confidently with FFRangio†
-
91%
Sensitivity
-
94%
Specificity
-
93%
Diagnostic Accuracy
The FFRangio System consistently demonstrates excellent diagnostic performance compared to traditional FFR wires, with strong results across a wide spectrum of patients and lesion subgroups.
View Clinical StudiesEasy Clinical
Integration
Quick, real-time intraprocedural results when you need it
Eliminate risk, complexity, and limitations of invasive FFR wires and hyperemic agents
Compatible with all major C-arm angiography systems
Improve outcomes while reducing costs‡
* Diagnostic performance of FFRangio compared to FFR wires has not been established for lesions immediately after PCI.
** Patent pending
† Witberg, et al. Diagnostic performance of angiogram-derived fractional flow reserve. J Am Coll Cariol Intv 2020. DOI: 10.1016/j.jcin.2019.10.045
‡FAME trial: FFR-guided PCI improves outcomes and reduces cost compared to angiography-guided PCI. Tonino, et al. N Engl J Med. January 15, 2009; 360:213-224; Fearon et al. Circulation. 2010;122:2545-2550;
